decisionhealth Newsletters, Part B News - 2001 Issue 7 (July)
Medicare needs policy for follow-up visits, specialty groups say
Subscribe or sign in to view the full article.
Article Overview
This article discusses how Medicare contractors handle follow-up visits for patients after cancer treatment and why specialty organizations say the current approach is inconsistent. It summarizes concerns raised by dermatology, surgery, and medical association representatives, along with CMS commentary about the lack of national instructions and the need for clearer, more standardized guidance. The piece is relevant to physicians, coders, compliance staff, and practices that bill evaluation and management services tied to a history of cancer.
Why This Topic Matters
Payment for follow-up care affects access, documentation, and claim acceptance for patients who need ongoing surveillance after cancer treatment. Understanding the policy uncertainty helps practices anticipate denials and recognize why specialty groups are urging more consistent Medicare handling of these visits.
Article Sections
-
Carrier variation in follow-up visit payment
Summarizes concerns that Medicare contractors do not handle post-treatment follow-up visits consistently. It frames the issue as a payment and medical-necessity question affecting cancer surveillance care.
-
Specialty society and CMS perspectives
Presents views from specialty organizations and a CMS spokesperson about how these services are being evaluated. It also notes calls for more standardized policy guidance and regulatory clarity.
-
Examples cited in physician comments
Describes examples referenced by physicians and professional groups to illustrate the scope of the dispute. The discussion stays focused on the policy context rather than on coding specifics.
What You Will Learn
- How Medicare contractor decisions can differ for follow-up visits after cancer treatment
- Why specialty societies считают the issue important for ongoing cancer surveillance
- What general types of policy clarification stakeholders are seeking from CMS
- How physician groups characterize the distinction between follow-up care and routine screening
Who Should Read This
- Physicians
- Medical coders
- Billing staff
- Compliance professionals
- Practice administrators
- Oncology and dermatology practices
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com